Jeffrey Sutton, MD
Dr. Jeffrey Sutton is a surgical oncologist with expertise in cytoreduction and heated intraperitoneal chemotherapy (CRS-HIPEC) for the treatment of peritoneal metastases, including malignant peritoneal mesothelioma. He is fellowship-trained and has specialized experience in the use of robotic and laparoscopic techniques for the treatment of soft tissue malignancies.[1]
When Dr. Sutton joined the Medical University of South Carolina and its affiliated Hollings Cancer Center, he was asked to lead and expand the multidisciplinary team that performs HIPEC for peritoneal surface malignancies. The procedure is a unique combination where all signs of cancer are surgically removed from the surface of organs, and then a heated chemotherapy solution is poured into the surgical site to kill any remaining microscopic cancer cells that can’t be seen or felt.[2]
Because the chemotherapy is delivered directly into the abdomen rather than systemically, 90% of the drugs remain in the abdomen and systemic adverse effects are avoided. This means that a more concentrated solution can be used. The treatment has proven to be extremely effective.
Education and Career
Dr. Sutton earned his medical degree at the University of Cincinnati College of Medicine and remained at that facility for his Surgical internship and residency, where he received numerous awards for teaching residents and medical students as well as for his research. Dr. Sutton then went on to complete a Complex General Surgical Oncology Fellowship at the University of Pittsburgh Medical Center in Pittsburgh, one of the highest-volume HIPEC surgery centers in the country. While in Pittsburgh, he also earned a certificate in Medical Education.[]
Following his medical education, Dr. Sutton accepted a role as an assistant professor of Surgery and associate program director for the General Surgery residency program in the Department of General Surgery at the University of Toledo Medical Center/ProMedica Toledo Hospital in Toledo, Ohio.[1]
Professional Memberships and Activities
Dr. Sutton is an active member of the following national societies:[1]
- Society of Surgical Oncology
- Association for Surgical Education
- American College of Surgeons
- Association of Academic Surgery
- Society for Surgery of the Alimentary Tract
- Pancreas Club
Research
Dr. Sutton is a diligent researcher who has published 48 peer-reviewed manuscripts. He has 27 oral presentations and 24 poster presentations to his credit, for many of which he was Lead Author.[footnotenum=”1″]
Terri Heimann Oppenheimer
WriterTerri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Dave Foster
Page EditorDave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.
References
- MUSC Health. (N.D.). Jeffrey Sutton, MD.
Retrieved from: https://providers.muschealth.org/sc/summerville/jeffrey-sutton-md - Hollings Cancer Center. (May 10, 2023.). Cytoreductive surgery and HIPEC offer hope to patients with difficult to treat abdominal cancers.
Retrieved from: https://hollingscancercenter.musc.edu/news/archive/2023/05/10/cytoreductive-surgery-and-hipec-offer-hope-to-patients-with-difficult-to-treat-abdominal-cancers